Development of an optimized protocol for generating knockout cancer cell lines using the CRISPR/Cas9 system, with

Seyed Alireza Mousavi Kahaki1, Nayereh Ebrahimzadeh2, Hossein Fahimi1

  • 1Faculty of Advanced Science and Technology, Department of Genetics, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Plos One
|November 14, 2024
PubMed

Insights

This study presents an optimized CRISPR gene editing protocol for generating cancer cell lines with gene knockouts in ten weeks. The method enhances efficiency and reduces off-target effects, making CRISPR more accessible for cancer research and personalized medicine.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • CRISPR gene editing offers advantages over traditional methods.
  • Off-target effects are a significant challenge in CRISPR applications.
  • Accessible gene editing protocols are needed for researchers with limited resources.

Purpose of the Study:

  • To develop an optimized CRISPR protocol for generating knockout cancer cell lines.
  • To minimize off-target effects through rigorous gRNA design.
  • To provide a cost-effective and efficient method for generating knockout cell lines within ten weeks.

Main Methods:

  • Utilized transient transfection for gene editing.
  • Implemented strict guidelines for guide RNA (gRNA) design to reduce off-target mutations.
  • Employed bioinformatics tools, cell assays, limiting dilution for monoclonal isolation, and knockout validation.
  • Applied the protocol to generate EpCAM gene knockouts in colorectal cancer cell lines.

Main Results:

  • Successfully generated colorectal cancer cell lines with monoallelic and biallelic EpCAM gene knockouts.
  • The protocol demonstrated high efficiency and reduced off-target effects.
  • The method is optimized for a wide range of cancer cell lines.

Conclusions:

  • The developed CRISPR protocol provides an accessible, efficient, and precise method for generating knockout cancer cell lines.
  • This advancement facilitates personalized and precision medicine applications in cancer research.
  • The protocol expands opportunities for investigating cancer mechanisms and developing therapeutic interventions.